Microbot Medical Inc. MBOT Cash Flow

Microbot medical inc. (MBOT)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating activities:
Net loss
-2,205	-1,870	-1,874	-1,542	-1,961	-2,126	-1,759	-1,893	-1,482	-1,587	-1,187	-3,508	-1,307	-8,571	-652	-164	-276	-399	17,290	-8,461	-9,350	21,285	-2,757	-12,115	-7,620	-6,962	-7,191	-5,868	-6,416	-2,758	-16,336	833	-10,229	-7,211	-4,334	-4,035	-5,747
Adjustments to reconcile net loss to net cash flows from operating activities:
Interest and revaluation of convertible notes, net
-	-	-	-	-	-	-	0	-	-	-	66	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and amortization of discount on convertible notes
-	-	-	-	-	-	-	-	-	-	0	-	-169	382	-27	0	-22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revaluation of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing loss on debt extinguishment
-	-	-	-	-	-	-	0	-	-	0	-2,364	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in fair value of derivative warrant liability
-	-	-	-	-	-	-	-1	-	-	-	-187	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount and issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	32	42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount and issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	64	72	-	-	-	-	-	-	-	-	-	-	-	-
Gain on disposal of fixed assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	148	-	-	-	-	3	0	-3	38	-	-	-	-	0	-0	-32	0
Changes in fair value of derivative warrant liability
-	-	-	-	-	-	-	-	-	-	1	-	-88	-	0	0	0	-	-	-988	347	-	-4,076	3,654	326	-2,827	143	-757	188	-	-	-	-	-	-	-	-
Shares issued as consideration-vendor
-	-	-	-	-	-	-	74	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
17	40	19	14	11	-	-	-	-	-	-	-	-	-	-	-	-	-	-	276	269	-	321	335	335	328	258	232	239	232	238	249	271	290	304	307	305
Depreciation
-	-	-	-	-	-	-	13	10	6	3	6	6	1	3	2	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation expense
343	193	296	295	315	260	317	406	416	303	22	154	0	-	0	0	-	-	-	1,351	1,308	-1,357	508	513	521	575	597	749	686	650	767	723	736	624	687	1,014	934
Changes in assets and liabilities:
Increase in restricted cash
-	-	-	-	-	-	-	0	-	-	0	27	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued interest and other receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16	-85	-	-	-	-387	-	296	15	53	-	-	-	-	-	-	-	-
Prepaid expenses and other assets
110	-	-	-	445	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-136	-46	-	312	273	-102	-18	-705	20	-97	148	-67	31	-134	-30	-542	71	5
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14	-138	-	-13	-15	-8	53	-23	7	-41	9	-24	19	44	-349	324	-1	-41
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,941	-	1,697	3,020	1,782
Other receivables
-	-	-	-	-	-	-	60	78	-183	-72	165	104	-540	12	-3	-7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-20	78	-281	210	71
Other payables and accrued liabilities
-3,966	-	225	-43	-643	-	-23	112	-60	-205	-260	-161	557	70	213	91	-50	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash flows from operating activities
-5,921	-1,920	-1,331	-477	-2,723	-1,435	-1,332	-1,349	-1,194	-1,309	-1,349	-1,431	-767	-19	-421	-53	-293	-	-	-	-	-	-6,683	-7,769	-6,507	-6,889	-6,002	-3,778	-6,652	-4,919	-4,234	-5,084	-5,630	-5,212	-3,714	-5,712	-7,418
Investing activities:
Purchase of property and equipment
68	-	-	-	-	-16	15	91	133	30	0	6	22	25	0	0	0	0	-554	334	221	-587	235	132	230	124	2,135	2,100	319	53	2	13	4	-33	214	99	16
Sales or maturities of marketable debt securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	758	0
Proceeds from sales of marketable security
2,521	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,404	8,470	4,556	-	1,700	450	3,212	-	-	-	-
Exercise of warrants
-	-	-	-	-	-	-	-	-	-	0	-	-	-	154	-	-	-	-	-	-	-	-	-	-	70	-0	13	447	2,102	959	2,465	728	-	-	-	0
Sales of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	148	-	-	-	-	0	0	0	38	-	-	-	-	-	0	7	35
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-546	-54	-5	112	-56	-17	-7	-8	-57	-15	-0	-3
Accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	94	-1,630	-	-327	53	-637	1,643	-792	2,090	-798	1,203	-92	-356	-1,163	272	754	287	-1,183
Accrued wind-down expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	628	474	214	180	321	315	344	290	237	293
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4	-4	-	-20	-21	-10	-5	38	-29	-28	14	24	-16	-8	-14	26	-14	-15
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-13	-10	-	-1	2	4	4	39	376	15	15	23	65	-19	2,336	-318	-318	-397
Net cash used for operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15,991	-7,577	-8,907	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of marketable security
-	0	0	0	2,496	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	159	-21	78	471	8,270	6,031	2	2,076	-35	498	1,342	8,382
Acquisition of other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-36	0	0	100	-	-	-	-	-	-	-	-
Net cash flows from investing activities
2,453	43	0	0	-2,496	16	-15	-91	-133	-3	0	-33	-22	-25	0	0	0	-	-	-	-	-	-235	-132	-230	-248	-710	6,291	3,703	-7,924	-4,333	434	1,131	1,956	3,663	-677	-8,364
Financing activities:
Outflow (inflow) in connection with current assets and liabilities acquired in reverse recapitalization, net
-	-	-	-	-	-	-	0	-	-	0	-126	208	-2,002	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used for investment activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	406	-334	-73	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock and warrants, net of issuance costs
-	27,208	0	0	9,562	-	-	0	-	-2	0	9,414	3,290	0	0	0	0	-	-	-	-	-	-	-	-	17,376	1,203	3,343	1,568	-	-	-	-	9,348	901	125	9,399
Issuance of convertible notes
-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	750	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	-	-	-	-	-	-	-	-
Net cash flows from financing activities
-	27,208	0	0	9,562	-	-	0	-	397	0	9,540	3,082	2,179	154	750	0	-	-	-	-	-	21,293	-717	2,615	16,767	4,910	13,008	1,715	5,605	17,077	2,403	650	9,277	837	-128	9,143
Increase (decrease) in cash, cash equivalents and restricted cash
-3,468	25,331	-1,331	-477	4,343	-1,437	-1,347	-1,440	-1,327	-942	-1,322	8,076	2,293	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	64	78	-	112	131	141	155	160	100	10	10	11	14	14	14	16	19	20
Non-cash activities:
Cashless exercise of warrants issued upon conversion of notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-1,349	-	-	-	-267	697	-293	-	-	-	-	-	-	-8,618	-4,122	-	-1,801	15,521	-1,233	-7,237	8,509	-2,246	-3,848	6,020	785	-6,518	-6,639
Payments related to net share issuance of stock based awards
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	243	142	-	0	297	201	0	12	81	248	0	29	16	13	7	2	196	197
Repayment of capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	-	5	5	5	5	3	1	1	1	0	0	17	17	17	16	16
Proceeds from the exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1	0
Proceeds from loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,955	0	3,820	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,016	1,681	-	988	1,009	998	-	-	-	-	-	48	46	46	-	45	42	42
Net cash generated by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23,677	-1,829	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,450	15,765	-10,810	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effects of foreign exchange rate changes on cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17	-31	-	-8	2	0	0	4	0	-6	-3	0	-4	-8	-3	-25	-14	-2
Supplemental disclosure of cash flow information:
Cash received from interest
-	36	40	13	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cashless exercise of warrants
-	-	-	-	-	-	-	0	-	-	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of Series A Convertible Preferred Stock into common stock
-	-	-	-	-	-	-	15	15	-2,020	27	2,083	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Extinguishment of convertible notes in exchange for Series A Convertible Preferred Stock
-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-